{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:50:53Z","timestamp":1780350653747,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.intimp.2010.04.027","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T08:46:06Z","timestamp":1274431566000},"page":"892-899","source":"Crossref","is-referenced-by-count":35,"title":["Atorvastatin affects TLR4 clustering via lipid raft modulation"],"prefix":"10.1016","volume":"10","author":[{"given":"Praveen","family":"Chansrichavala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udom","family":"Chantharaksri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyamitr","family":"Sritara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathamon","family":"Ngaosuwankul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sansanee C.","family":"Chaiyaroj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2010.04.027_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2010.04.027_bib2","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2010.04.027_bib3","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2010.04.027_bib4","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.ATV.0000022694.16328.CC","article-title":"Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients","volume":"22","author":"Rezaie-Majd","year":"2002","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.intimp.2010.04.027_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2004.07.003","article-title":"Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients","volume":"177","author":"Ascer","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2010.04.027_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2010.04.027_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1567-5688(01)00010-1","article-title":"Immunosuppressive effects of statins","volume":"3","author":"Mach","year":"2002","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.intimp.2010.04.027_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-9150(99)00193-8","article-title":"Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells","volume":"147","author":"Ortego","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2010.04.027_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0008-6363(02)00619-3","article-title":"Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet","volume":"57","author":"Hernandez-Presa","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2010.04.027_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cccn.2004.10.007","article-title":"Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein","volume":"353","author":"Wang","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.intimp.2010.04.027_bib11","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2010.04.027_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMoa012673","article-title":"Toll-like receptor 4 polymorphisms and atherogenesis","volume":"347","author":"Kiechl","year":"2002","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.intimp.2010.04.027_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2006.12.024","article-title":"Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure","volume":"124","author":"Foldes","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.intimp.2010.04.027_bib14","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1161\/CIRCULATIONAHA.104.498865","article-title":"Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome","volume":"111","author":"Methe","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2010.04.027_bib15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nm1008","article-title":"Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways","volume":"10","author":"Bjorkbacka","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2010.04.027_bib16","first-page":"49","article-title":"Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway","volume":"27","author":"Chansrichavala","year":"2009","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.intimp.2010.04.027_bib17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2010.04.027_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/smim.2000.0302","article-title":"Floating the raft hypothesis: the roles of lipid rafts in B cell antigen receptor function","volume":"13","author":"Cheng","year":"2001","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2010.04.027_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1074-7613(01)00156-X","article-title":"Floating the raft hypothesis: lipid rafts play a role in immune cell activation","volume":"14","author":"Cherukuri","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2010.04.027_bib20","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1242\/jcs.115.12.2603","article-title":"Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation","volume":"115","author":"Triantafilou","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.intimp.2010.04.027_bib21","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.4049\/jimmunol.164.7.3471","article-title":"Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages","volume":"164","author":"Akashi","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2010.04.027_bib22","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1074\/jbc.275.4.2251","article-title":"Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol","volume":"275","author":"Kawasaki","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2010.04.027_bib23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/CDLI.11.3.483-495.2004","article-title":"Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant","volume":"11","author":"Okamoto","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.intimp.2010.04.027_bib24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.biopha.2007.03.002","article-title":"Simvastatin and fluvastatin reduce interleukin-6 and interleukin-8 lipopolysaccharide (LPS) stimulated production by isolated human monocytes from chronic kidney disease patients","volume":"61","author":"Mantuano","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2010.04.027_bib25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2174\/138161207780487548","article-title":"Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?","volume":"13","author":"Akdim","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2010.04.027_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/01.fjc.0000194252.38683.68","article-title":"Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization","volume":"47","author":"Gomez-Hernandez","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.intimp.2010.04.027_bib27","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.ATV.18.11.1707","article-title":"Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques","volume":"18","author":"Johnson","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2010.04.027_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2004.04.027","article-title":"Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques","volume":"176","author":"Yilmaz","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2010.04.027_bib29","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1073\/pnas.95.15.8880","article-title":"Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase","volume":"95","author":"Endres","year":"1998","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2010.04.027_bib30","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI1500","article-title":"Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells","volume":"101","author":"Hernandez-Perera","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2010.04.027_bib31","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2010.04.027_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2010.04.027_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.intimp.2010.04.027_bib34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.20021425","article-title":"Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin","volume":"197","author":"Aktas","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2010.04.027_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.intimp.2010.04.027_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/07853890510007304","article-title":"Atherosclerosis and innate immune signaling","volume":"37","author":"Laberge","year":"2005","journal-title":"Ann. Med."},{"key":"10.1016\/j.intimp.2010.04.027_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2310\/6650.2006.05051","article-title":"Atherosclerosis: immune and inflammatory aspects","volume":"54","author":"Reiss","year":"2006","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.intimp.2010.04.027_bib38","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/01.STR.0000226901.34927.10","article-title":"Inflammation and atherosclerosis: novel insights into plaque formation and destabilization","volume":"37","author":"Stoll","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2010.04.027_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2003.10.002","article-title":"HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis","volume":"172","author":"Yilmaz","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2010.04.027_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1189\/jlb.0205064","article-title":"Differential effects of statins on relevant functions of human monocyte-derived dendritic cells","volume":"79","author":"Yilmaz","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2010.04.027_bib41","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.atherosclerosis.2005.12.022","article-title":"Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo","volume":"189","author":"Niessner","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2010.04.027_bib42","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/01.ATV.0000168410.44722.86","article-title":"Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes","volume":"25","author":"Methe","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2010.04.027_bib43","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.4049\/jimmunol.177.10.7416","article-title":"Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus","volume":"177","author":"Jury","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2010.04.027_bib44","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/j.1530-0277.2006.00172.x","article-title":"Ethanol suppresses LPS-induced Toll-like receptor 4 clustering, reorganization of the actin cytoskeleton, and associated TNF-alpha production","volume":"30","author":"Dai","year":"2006","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.intimp.2010.04.027_bib45","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2004.03.018","article-title":"Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease","volume":"175","author":"Hillyard","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2010.04.027_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2003.11.004","article-title":"Fluvastatin inhibits raft dependent Fcgamma receptor signalling in human monocytes","volume":"172","author":"Hillyard","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2010.04.027_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.atherosclerosis.2006.05.037","article-title":"Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation","volume":"191","author":"Hillyard","year":"2007","journal-title":"Atherosclerosis"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576910001566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576910001566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T02:32:39Z","timestamp":1635388359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576910001566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1567576910001566"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2010.04.027","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}